US not liable in Moderna COVID vaccine patent case, says Second judge
A Moderna spokesperson said in a statement that the company "respectfully disagrees" with the decision and is confident that discovery will support its position.
Advertisement
New Delhi: Moderna Inc failed to persuade a Delaware federal judge on Wednesday to shift liability from the company to the U.S. government for alleged patent infringement by Moderna's COVID-19 vaccine.
Chief Judge Colm Connolly's ruling for Alnylam Pharmaceuticals Inc came just over a month after a different judge in Delaware rejected Moderna's similar motion in another vaccine patent lawsuit.
Connolly did not include the reasoning for his decision in his order, which he announced from the bench following arguments in the case.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.